Gene link fear in ovarian cancer
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.WOMEN WITH genes predisposing them to breast cancer are also ten times more likely to get ovarian cancer, says a study.
Myriad Genetics, the US firm which owns the patents for tests for the "breast cancer genes" BRCA1 and BRCA2, say the results from their survey of 238 women provide "clear guidelines to help doctors identify patients who should be evaluated for hereditary breast and ovarian cancer".
British experts have suggested Myriad's numbers may be exaggerated. The company charges about pounds 400 for each BRCA1 test, and would benefit hugely from widespread testing in the US and UK.
"This is a research area, not one for clinical medicine yet," said Professor Gordon McVie, director of the Cancer Research Campaign (CRC).
Myriad suggest "all women with breast cancer under age 50, and any woman with a history of breast or ovarian cancer in a close relative, should be tested". In the UK alone that would involve thousands of tests. An estimated 125,000 women in Britain have either the BRCA1 or BRCA2 gene.
"We would recommend women who are concerned about the possibility that they are carrying either gene to get their doctor to recommend them for testing at a regional genetic testing centre," said Professor McVie.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments